Senti Biosciences, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Senti Biosciences, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2021 to Q3 2024.
  • Senti Biosciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $14.5M, a 15% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $14.5M -$2.55M -15% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $15.3M -$2.17M -12.4% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $15.8M -$2.11M -11.8% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $16.3M -$2.14M -11.6% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 $17M -$1.87M -9.88% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $17.5M -$2.01M -10.3% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $17.9M Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $18.4M -$2.29M -11.1% Dec 31, 2022 10-K 2024-03-21
Q3 2022 $18.9M Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $19.5M Jun 30, 2022 10-Q 2022-08-15
Q4 2021 $20.7M Dec 31, 2021 10-K 2023-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.